🟢 Indaptus Therapeutics is trading 6.6% up in pre-market with no confirmed catalyst identified

Indaptus Therapeutics is trading 6.56% up at $1.30 in pre-market, with no clear company-specific catalyst identified.

• Searches found no clear company-specific announcement on September 8, 2026 explaining the move.
• The September 2 board resignation was described as routine and unrelated to company operations, making it an unlikely direct catalyst.
• Broader U.S. markets are lower; without confirmed catalyst or volume data, the gain may reflect speculative trading or limited liquidity.